U.S. Defense Secretary Pete Hegseth said the military will begin testing testosterone levels of some service members and recommending hormone therapy if needed.
This initiative represents a shift in how the Department of Defense manages hormonal health among active personnel. By identifying deficiencies early, the military aims to maintain the physical and mental readiness of its force.
Hegseth said the Pentagon will specifically begin testing testosterone of troops 30 and older [1]. The program is designed to identify service members who may require medical intervention to maintain optimal health standards.
"The military will begin testing the testosterone levels of some service members and recommending hormone therapy if needed," Hegseth said [2].
The Secretary linked the initiative to the overall quality of care provided to the armed forces. He said that the military has a responsibility to provide high-level medical support to those who serve in the field.
"We owe our warriors the absolute best medical care in the world, and this program delivers on that obligation," Hegseth said [3].
The announcement was shared via the social media platform X on Wednesday, March 13, 2024 [2]. The program focuses on ensuring that service members receive the best possible medical care to address potential hormone deficiencies [3].
While the program targets a specific age demographic, the broader goal is to integrate hormone screening into the standard medical evaluations for aging personnel. This approach allows the military to address health issues that can affect performance, and longevity in the service.
“"The Pentagon will begin testing testosterone of troops 30 and older,"”
The introduction of systematic testosterone screening for personnel aged 30 and above indicates a move toward proactive endocrine health management within the U.S. military. By institutionalizing hormone therapy recommendations, the Department of Defense is treating hormonal balance as a component of operational readiness, potentially reducing long-term health complications associated with age-related testosterone decline in high-stress environments.
